Severe hyperCKemia after levetiracetam with profound electrolyte disturbances
European Journal of Clinical Pharmacology · 2026-07 · 82 (7)
DOI: 10.1007/s00228-026-04109-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 17.06.2026. Verfasst von Yuma Sato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Chiyoda Hospital, 88 Furuta-cho, Hichiya, Hyuga, Miyazaki, 883-0064, Japan. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Neurology, Chiyoda Hospital, 88 Furuta-cho, Hichiya, Hyuga, Miyazaki, 883-0064, Japan.
- Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
- Department of Neurology, Chiyoda Hospital, 88 Furuta-cho, Hichiya, Hyuga, Miyazaki, 883-0064, Japan. nobuyuki_ishii@med.miyazaki-u.ac.jp.
- Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. nobuyuki_ishii@med.miyazaki-u.ac.jp.
Zitieren
APA
Sato, Y., & Ishii, N. (2026). Severe hyperCKemia after levetiracetam with profound electrolyte disturbances. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04109-4
Vancouver
Sato Y, Ishii N. Severe hyperCKemia after levetiracetam with profound electrolyte disturbances. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04109-4
BibTeX
@article{Sato2026,
author = {Sato, Yuma and Ishii, Nobuyuki},
title = {Severe hyperCKemia after levetiracetam with profound electrolyte disturbances},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {7},
doi = {10.1007/s00228-026-04109-4}
}
EUVIMED